A detailed history of Neuberger Berman Group LLC transactions in Novartis Ag stock. As of the latest transaction made, Neuberger Berman Group LLC holds 167,424 shares of NVS stock, worth $19.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
167,424
Previous 175,258 4.47%
Holding current value
$19.4 Million
Previous $17 Million 5.14%
% of portfolio
0.02%
Previous 0.01%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $725,193 - $841,136
-7,834 Reduced 4.47%
167,424 $17.8 Million
Q1 2024

May 13, 2024

BUY
$95.27 - $108.47 $16.7 Million - $19 Million
175,258 New
175,258 $17 Million
Q4 2023

Feb 09, 2024

SELL
$92.27 - $101.54 $4.65 Million - $5.12 Million
-50,380 Reduced 19.18%
212,233 $21.4 Million
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $1.48 Million - $1.64 Million
-15,591 Reduced 5.6%
262,613 $26.7 Million
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $2.08 Million - $2.36 Million
-22,493 Reduced 7.48%
278,204 $28.1 Million
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $2.78 Million - $3.23 Million
-34,753 Reduced 10.36%
300,697 $27.7 Million
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $29.9 Million - $36.6 Million
-395,259 Reduced 54.09%
335,450 $30.4 Million
Q3 2022

Nov 15, 2022

SELL
$74.61 - $87.26 $6.57 Million - $7.69 Million
-88,091 Reduced 10.76%
730,709 $55.6 Million
Q2 2022

Aug 15, 2022

SELL
$80.52 - $93.75 $272,399 - $317,156
-3,383 Reduced 0.41%
818,800 $69.2 Million
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $3.6 Million - $4.07 Million
-44,936 Reduced 5.18%
822,183 $70.4 Million
Q4 2021

Feb 11, 2022

SELL
$79.7 - $88.13 $12.4 Million - $13.7 Million
-155,039 Reduced 15.17%
867,119 $74.8 Million
Q3 2021

Nov 12, 2021

SELL
$81.78 - $95.14 $3.71 Million - $4.31 Million
-45,328 Reduced 4.25%
1,022,158 $83.4 Million
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $17.9 Million - $19.8 Million
-209,953 Reduced 16.44%
1,067,486 $96.8 Million
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $14.8 Million - $17.4 Million
-176,824 Reduced 12.16%
1,277,439 $109 Million
Q4 2020

Feb 10, 2021

SELL
$78.07 - $94.43 $58.5 Million - $70.8 Million
-749,624 Reduced 34.01%
1,454,263 $137 Million
Q3 2020

Nov 12, 2020

SELL
$82.14 - $91.0 $23.7 Million - $26.2 Million
-288,365 Reduced 11.57%
2,203,887 $192 Million
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $34.9 Million - $39.3 Million
431,326 Added 20.93%
2,492,252 $218 Million
Q1 2020

May 14, 2020

SELL
$70.67 - $99.01 $1.57 Million - $2.2 Million
-22,189 Reduced 1.07%
2,060,926 $170 Million
Q4 2019

Feb 12, 2020

BUY
$84.35 - $95.37 $5.25 Million - $5.94 Million
62,243 Added 3.08%
2,083,115 $197 Million
Q3 2019

Nov 13, 2019

SELL
$85.54 - $94.26 $1.16 Million - $1.27 Million
-13,524 Reduced 0.66%
2,020,872 $176 Million
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $18.7 Million - $23 Million
247,786 Added 13.87%
2,034,396 $186 Million
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $22 Million - $25.2 Million
292,485 Added 19.58%
1,786,610 $172 Million
Q4 2018

Feb 12, 2019

BUY
$73.66 - $82.02 $87.4 Million - $97.3 Million
1,186,687 Added 385.99%
1,494,125 $128 Million
Q3 2018

Nov 13, 2018

SELL
$66.94 - $77.43 $1.08 Million - $1.25 Million
-16,115 Reduced 4.98%
307,438 $26.5 Million
Q2 2018

Aug 13, 2018

SELL
$64.91 - $73.36 $3.72 Million - $4.2 Million
-57,259 Reduced 15.04%
323,553 $24.4 Million
Q1 2018

May 08, 2018

SELL
$70.39 - $84.15 $158,025 - $188,916
-2,245 Reduced 0.59%
380,812 $30.8 Million
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $3.68 Million - $3.95 Million
50,878 Added 15.32%
383,057 $32.2 Million
Q3 2017

Nov 15, 2017

BUY
$74.14 - $77.27 $24.6 Million - $25.7 Million
332,179
332,179 $28.5 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $249B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.